Novocol Pharmaceutical of Canada Inc.
$500,000.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- September 8, 2020 – September 30, 2021
- Reference
- nrc-cnrc:172-2020-2021-Q3-958184
Published purpose
Design of a facility, inclusive of engineering design and research in innovative formulation and fill-finish manufacturing of vaccines, therapies and other biopharmaceuticals using a Ready-To-Use (RTU) container platform for vials and prefilled syringes. Novocol Pharma is a world-class commercial aseptic fill-finish operation with multiple fill-finish suites and scientific/technical support departments (Microbiology, Chemistry, Product Development, Engineering, Validation, Stability and Analytical Services). An existing warehouse building will be renovated to create injectable vaccine/therapy fill-finish operations with two formulation/ filling clean rooms, each equipped with innovative aseptic VanRx filling work cells... see attachment
Community tags
Tags are applied by readers, not by this site. One tag per person per record.